Curonix Foundational Clinical Data Published Within the American Society of Interventional Pain Physicians (ASIPP) Peripheral Nerve Stimulation Guidelines for the Management of Chronic Pain Curonix Foundational Clinical Data Published Within the American Society of Interventional Pain Physicians (ASIPP) Peripheral Nerve Stimulation Guidelines

Curonix Receives the First Full-Body Peripheral Nerve Stimulator (PNS) FDA Clearance, including Craniofacial Pain Indication, for its Freedom® PNS System Curonix Receives the First Full-Body Peripheral Nerve Stimulator (PNS) FDA Clearance, including Craniofacial Pain Indication, for its Freedom® PNS System.

Curonix Celebrates 1st Anniversary POMPANO BEACH, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Today, Curonix LLC, a leading peripheral nerve stimulation company celebrated its first anniversary. In November 2022, Curonix completed the...

Curonix Provides Reimbursement Update on Neurostimulator Procedure Codes POMPANO BEACH, Fla., July 18, 2023 (GLOBE NEWSWIRE) -- Today, Curonix LLC provided an update on the Medicare Physician Fee Schedule Proposed Rule published by the Centers for Medicare & Medicaid...